PH21000A - Liquid formulations of dihydropyridines - Google Patents

Liquid formulations of dihydropyridines

Info

Publication number
PH21000A
PH21000A PH30312A PH30312A PH21000A PH 21000 A PH21000 A PH 21000A PH 30312 A PH30312 A PH 30312A PH 30312 A PH30312 A PH 30312A PH 21000 A PH21000 A PH 21000A
Authority
PH
Philippines
Prior art keywords
alkyl
parts
dihydropyridines
liquid formulations
dihydropyridine
Prior art date
Application number
PH30312A
Other languages
English (en)
Inventor
Hoff Dieter
Ramsch Klaus-Dieter
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6192336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH21000(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PH21000A publication Critical patent/PH21000A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
PH30312A 1983-03-03 1984-02-29 Liquid formulations of dihydropyridines PH21000A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833307422 DE3307422A1 (de) 1983-03-03 1983-03-03 Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen

Publications (1)

Publication Number Publication Date
PH21000A true PH21000A (en) 1987-06-22

Family

ID=6192336

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30312A PH21000A (en) 1983-03-03 1984-02-29 Liquid formulations of dihydropyridines

Country Status (20)

Country Link
US (1) US4537898A (da)
EP (1) EP0117888B2 (da)
JP (1) JPS59167512A (da)
KR (1) KR900004091B1 (da)
AT (1) ATE29665T1 (da)
AU (1) AU566408B2 (da)
CA (1) CA1212326A (da)
DE (2) DE3307422A1 (da)
DK (1) DK163961C (da)
ES (1) ES530115A0 (da)
GR (1) GR79546B (da)
HK (1) HK41290A (da)
HU (1) HU194048B (da)
IE (1) IE57158B1 (da)
IL (1) IL71097A (da)
IT (1) IT1212724B (da)
NO (1) NO840770L (da)
PH (1) PH21000A (da)
PT (1) PT78149B (da)
ZA (1) ZA841584B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222474A (ja) * 1983-06-02 1984-12-14 Teijin Ltd １，４―ジヒドロピリジン―３，５―ジカルボン酸ジエステル誘導体の製造法
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
EP0175671A1 (de) † 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
EP0175269B1 (en) * 1984-09-21 1991-03-06 University Of Iowa Research Foundation Immunogen conjugates and the use thereof in a dihydropyridine assay
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition
DE3447170A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0188311A3 (en) * 1985-01-07 1988-07-20 Syntex (U.S.A.) Inc. Pharmaceutical formulation of nicardipine and 1,2-dioxy-omega-trialkylammonium compounds
GB2180532B (en) * 1985-09-17 1989-08-23 Inst Organicheskogo Sinteza Ak Alkoxy-and phenoxy-alkyl-esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
AT387518B (de) * 1985-12-18 1989-02-10 Bayer Ag Verfahren zur herstellung von fluessigen spruehpraeparaten von dihydropyridinen
DE3775960D1 (de) * 1986-03-10 1992-02-27 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
US4782070A (en) * 1986-07-01 1988-11-01 Fujisawa Pharmaceutical Co., Ltd. Cerebral dysfunction therapeutic agent, which comprises a dihydropyridine compound
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
US5001139A (en) * 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
US5160734A (en) * 1987-11-25 1992-11-03 American Cyanamid Company Sustained release delivery system for substituted dihydropyridine calcium channel blockers
NZ227700A (en) * 1988-01-29 1990-09-26 Merrell Dow Pharma Liquid pharmaceutical compositions containing 4-aroylimidazol-2-ones and nonionic surfactants
US5478848A (en) * 1994-01-26 1995-12-26 Bayer Corporation Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine
HU214582B (hu) * 1994-07-26 1998-04-28 EGIS Gyógyszergyár Rt. Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására
ES2133052B1 (es) * 1996-04-29 2000-05-01 Almirall Prodesfarma Sa Nuevas formulaciones farmaceuticas liquidas para la via oral.
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
US20070117851A1 (en) * 2005-10-14 2007-05-24 Transform Pharmaceuticals, Inc. Liquid pharmaceutical compositions of nimodipine
ES2446363T3 (es) 2009-12-28 2014-03-07 Laboratorio Reig Jofre S.A. Composición farmacéutica oral de nifedipino
CN105168175A (zh) * 2015-08-25 2015-12-23 瑞阳制药有限公司 尼索地平胶囊及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
SU432703A3 (da) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
JPS5335124A (en) * 1976-09-10 1978-04-01 Nippon Denso Co Ltd Converter
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
JPS57167911A (en) * 1981-04-09 1982-10-16 Kyoto Yakuhin Kogyo Kk Liquid pharmaceutical of nifedipine

Also Published As

Publication number Publication date
ATE29665T1 (de) 1987-10-15
IE57158B1 (en) 1992-05-20
IT8320301A0 (it) 1983-03-25
DE3307422A1 (de) 1984-09-06
DE3373625D1 (en) 1987-10-22
DK163961B (da) 1992-04-27
ES8503948A1 (es) 1985-04-16
EP0117888B1 (de) 1987-09-16
CA1212326A (en) 1986-10-07
DK163961C (da) 1992-09-21
US4537898A (en) 1985-08-27
PT78149A (en) 1984-03-01
PT78149B (en) 1986-05-19
KR840008278A (ko) 1984-12-14
HU194048B (en) 1988-01-28
IL71097A0 (en) 1984-05-31
AU566408B2 (en) 1987-10-22
AU2520584A (en) 1984-09-06
DK108684D0 (da) 1984-02-27
JPH0460092B2 (da) 1992-09-25
NO840770L (no) 1984-09-04
IT1212724B (it) 1989-11-30
ZA841584B (en) 1985-06-26
IL71097A (en) 1987-09-16
EP0117888A1 (de) 1984-09-12
KR900004091B1 (ko) 1990-06-15
HK41290A (en) 1990-06-08
JPS59167512A (ja) 1984-09-21
ES530115A0 (es) 1985-04-16
IE840517L (en) 1984-09-03
GR79546B (da) 1984-10-30
EP0117888B2 (de) 1992-08-26
DK108684A (da) 1984-09-04

Similar Documents

Publication Publication Date Title
PH21000A (en) Liquid formulations of dihydropyridines
NZ260561A (en) 2-n-butyl-4-alkyl(-thio, -sulphinyl and -sulphonyl) imidazol-5-carboxylic acid (and ester) and -5-carboxaldehyde derivatives
IL73258A0 (en) 7-aminoazolo(1,5-a)pyrimidines,their preparation and their use as fungicides
DK599785A (da) Blokpolyestere og detergentkompositioner indeholdende disse
DK0379412T3 (da) Derivater af 1,8-benzonaphthyridin, fremstilling af disse forbindelser og midler, som indeholder forbindelserne
DK27084D0 (da) Kompositioner aktive mod mider,mellus og thrips,farmaceutisk komposition og benzoylurinstof-forbindelser
IE880628L (en) Substituted pyridine-2,4-dicarboxylic acid derivatives,¹processes for their preparation, the use thereof and¹medicaments based on these compounds
DK61785A (da) 2-alkoxyaminosulfonylbenzensulfonylurinstofderivater, deres fremstilling og anvendelse som herbicider
GR3001542T3 (en) Benzofuran carboxamides with basic substituents, process for their preparation and therapeutical compositions containing them
DE3166726D1 (en) Pyridine derivatives, their preparation and uses
IL95608A0 (en) 1-methoxypyrimidinyl-n-nitro-phenyl-1h,1,2,4-triazole-3-sulphonamide derivatives and herbicidal compositions containing the same
DK0381508T3 (da) Anvendelse af cinnamamid til relaksation af muskeltonus
SE8400118L (sv) Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
DK0427160T3 (da) Benzylselenobenzamid af aminopyridiner og picolylaminer
HU900600D0 (en) Herbicide compositions containing substituted sulfonyl-carbamide-derivatives and process for preparation of the agents